| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/01/2011 | CN102083854A Glycosylated GLP-1 peptide |
| 06/01/2011 | CN102083813A Piperidinyl gpcr agonists |
| 06/01/2011 | CN102083810A Activator for peroxisome proliferator-activated receptor |
| 06/01/2011 | CN102083805A 4,5-dihydro-oxazol-2-yl derivatives |
| 06/01/2011 | CN102083799A Benzimidazole derivatives used as FXR agonists |
| 06/01/2011 | CN102083783A Substituted biphenyl GPR40 modulators |
| 06/01/2011 | CN102083458A Super fast-acting insulin compositions |
| 06/01/2011 | CN102083445A Nutritive compositions and methods of using same |
| 06/01/2011 | CN102083419A Pharmaceutical composition containing surface-coated microparticles |
| 06/01/2011 | CN102083329A High protein liquid enteral nutritional composition |
| 06/01/2011 | CN102079821A Compositions comprising superhydrophilic amphiphilic copolymers and methods of use thereof |
| 06/01/2011 | CN102079790A Recombination fusion protein PACAP-PTD (Pituitary Adenylate Cyclase Activating Peptide-Protein Transduction Domain) as well as expression method and application thereof |
| 06/01/2011 | CN102079765A 9-O-glucoside-berberine salt, and preparation method and application thereof |
| 06/01/2011 | CN102079763A Dioxabicyclo-octane compound, preparation method and application thereof |
| 06/01/2011 | CN102079743A Dipeptidyl peptidase inhibitors |
| 06/01/2011 | CN102079726A Miazine compounds, intermediates of miazine compounds, preparation method of intermediates and miazine compounds as well as application of miazine compound |
| 06/01/2011 | CN102079692A Terphenyl compound and preparation method of terphenyl compound and application of terphenyl compound as alpha-glucosidase inhibitor |
| 06/01/2011 | CN102078636A Hydrogel dressing containing recombinant human epidermal growth factor and preparation method and application thereof |
| 06/01/2011 | CN102078608A Formulation of human antibodies for treating tnf-alpha associated disorders |
| 06/01/2011 | CN102078593A Application of toad peptide antibiotic for preparing medicines for curing diabetic foot |
| 06/01/2011 | CN102078562A Chinese medicinal oral liquid for treating children metabolic syndrome and preparation method thereof |
| 06/01/2011 | CN102078513A Chinese patent medicine for treating diabetes |
| 06/01/2011 | CN102078492A Preparation method and application of compound white paeony root preparation |
| 06/01/2011 | CN102078480A Nano element traditional Chinese medicine negative ion far infrared electromagnetic wave-resistant life prolonging medicinal liquor |
| 06/01/2011 | CN102078418A Compound traditional Chinese medicine extract for preventing and treating lipid metabolism disorder and preparation method thereof |
| 06/01/2011 | CN102078402A Traditional Chinese medicine composition for treating hypertension, hyperlipidemia and hyperglycemia |
| 06/01/2011 | CN102078397A Traditional Chinese medicine compound and preparation method thereof |
| 06/01/2011 | CN102078383A Compound ginkgo leaf capsule and tablet preparation method |
| 06/01/2011 | CN102078365A Soft capsule with auxiliary function of reducing blood fat and preparation method thereof |
| 06/01/2011 | CN102078356A Preparation method and applications of sugar-reducing effective part of chicory |
| 06/01/2011 | CN102078347A Method for preparing effective part in cumin seed |
| 06/01/2011 | CN102078345A Preparation method of actinidia arguta flavonoids |
| 06/01/2011 | CN102078340A Protein nutritious product as well as preparation method and application thereof |
| 06/01/2011 | CN102078335A Preparation method of latic acid hirudo liquid |
| 06/01/2011 | CN102078315A Application of ampelopsin in preparing medicines for treating obesity |
| 06/01/2011 | CN102078304A Insulin drug carried microspheres and preparation method thereof |
| 06/01/2011 | CN101797330B Lipid regulating and meridians activating capsule |
| 06/01/2011 | CN101690751B Hyperlipemia patient health preserving and protecting tea and method of preparing same |
| 06/01/2011 | CN101671331B Lipoyl vildagliptin as well as preparation method and application thereof |
| 06/01/2011 | CN101642547B Chinese patent medicine for treating diabetes |
| 06/01/2011 | CN101574343B Medicament composition for treating diabetes |
| 06/01/2011 | CN101554444B Traditional Chinese medicine tea |
| 06/01/2011 | CN101537050B Health product capable of enhancing bone density and immune function, and preparation method and applications thereof |
| 06/01/2011 | CN101502489B Intestinal nutrient solution with special medical goal |
| 06/01/2011 | CN101468097B Chinese medicinal composition for nourishing liver and kidney, moistening intestines and relaxing piss, preparation and method for preparing the same |
| 06/01/2011 | CN101450178B Medicine for treating diabetes |
| 06/01/2011 | CN101432262B Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 06/01/2011 | CN101379036B Anthranilamide/2-amino-heteroarene carboxamide derivatives |
| 06/01/2011 | CN101367840B Phosphine isocoumarin amide, synthesis and uses thereof |
| 06/01/2011 | CN101357218B Externally used medicine for treating diabetes and preparation method thereof |
| 06/01/2011 | CN101332228B Traditional Chinese medicine composition for treating disease with common pathogenic basis of 'insulin resistance', such as type II diabetic |
| 06/01/2011 | CN101204239B Celery red juice and its processing method thereof |
| 06/01/2011 | CN101125133B Unsaturated fatty acid microcapsule preparing technology and application |
| 06/01/2011 | CN101103995B Application of fly maggot chitosan in preparing product regulating blood sugar |
| 06/01/2011 | CN101099860B Use of erythropoietin |
| 06/01/2011 | CN101091587B Composition of raw material for preparing healthy inhalation articles or cigarettes as well as inhalation articles or cigarettes prepared from the composition |
| 05/31/2011 | US7951972 Human adam-10 inhibitors |
| 05/31/2011 | US7951830 Compounds effecting glucokinase |
| 05/31/2011 | US7951820 Triazole compounds useful as protein kinase inhibitors |
| 05/31/2011 | US7951805 Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase |
| 05/31/2011 | US7951803 8-heteroarylpurine MNK2 inhibitors for treating metabolic disorders |
| 05/31/2011 | US7951799 Lactam compound, a method for producing the same, and a diabetic therapy by administering the same |
| 05/31/2011 | US7951793 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 05/31/2011 | US7951371 Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling |
| 05/31/2011 | CA2598821C Organoselenium containing compounds and their use |
| 05/31/2011 | CA2598610C 1-sulfonyl-piperidine-3-carboxylic acid amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase for the treatment of type ii diabetes mellitus |
| 05/31/2011 | CA2583217C 1,3,4-thiadiazole compounds as protein kinase inhibitors |
| 05/31/2011 | CA2501734C Novel bicyclic inhibitors of hormone sensitive lipase |
| 05/31/2011 | CA2483241C Novel diazabicyclononene derivatives |
| 05/31/2011 | CA2475764C New inhibitors of histone deacetylase |
| 05/31/2011 | CA2465750C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]-indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 05/31/2011 | CA2412501C Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury |
| 05/31/2011 | CA2400929C Antagonistic selective binding agents of osteoprotegerin binding protein |
| 05/31/2011 | CA2369725C Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 05/31/2011 | CA2231772C Advanced glycation end-product intermediaries and post-amadori inhibition |
| 05/26/2011 | WO2011063414A1 Polypeptide conjugate |
| 05/26/2011 | WO2011063150A2 Oral formulation for dexlansoprazole |
| 05/26/2011 | WO2011062458A2 Composition containing homoisoflavanone as active ingredient for preventing and treating obesity or metabolic syndrome |
| 05/26/2011 | WO2011062253A1 Novel fused pyrimidine derivative |
| 05/26/2011 | WO2011062194A1 Aminopyridine derivative |
| 05/26/2011 | WO2011061743A1 Metadoxine and derivatives thereof for use in the treatment of inflammation and immune-related disorders |
| 05/26/2011 | WO2011061725A1 Antidiabetic composition containing a plant extract of englerina lecardii |
| 05/26/2011 | WO2011060583A1 Nonnatural collagen-like protein and use thereof |
| 05/26/2011 | WO2011060492A1 Combination for treating metabolic disorders |
| 05/26/2011 | WO2011041710A3 Docosahexaenoic acid gel caps |
| 05/26/2011 | WO2011039367A3 Pharmaceutical compositions comprising bi-1356 and metformin |
| 05/26/2011 | WO2011039308A3 Gluten-free foodstuff |
| 05/26/2011 | WO2011001283A3 Composition and method for reducing food intake |
| 05/26/2011 | WO2010151755A3 TREATMENT OF INFLAMMATORY DISEASES USING miR-124 |
| 05/26/2011 | WO2010148253A3 Formulations for lysosomal enzymes |
| 05/26/2011 | WO2010129343A3 Method of reducing fat accumulation and inducing weight loss |
| 05/26/2011 | US20110124887 Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidant activity |
| 05/26/2011 | US20110124743 Palatability enhancers and methods for enhancing palatability |
| 05/26/2011 | US20110124742 Composition and method of adipose cell differentiation inhibition |
| 05/26/2011 | US20110124733 Therapeutic or prophylactic agent for diabetes, obesity, dyslipidemia or metabolic syndrome comprising benzylamine derivative or pharmaceutically acceptable acid |
| 05/26/2011 | US20110124724 Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potasium level in the blood |
| 05/26/2011 | US20110124722 Compositions and methods for treating hypercholesterolemia using ortanique peel extract |
| 05/26/2011 | US20110124720 Compositions and methods for treating immune disorders |
| 05/26/2011 | US20110124704 Deuterium-enriched atorvastatin |
| 05/26/2011 | US20110124695 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors |